GRI Is Looking for Accomplished Nominees for Its Governance Bodies
GRI’s mission to empower decisions that create social, environmental and economic benefits for everyone, can only be fulfilled if everyone is represented. Once a year, there is an opportunity for experts in sustainability to become part of our governance bodies. We are currently seeking members for a term of 3 years - find out more!
Creating Good Homes at Kingfisher
Kingfisher, the home improvement company, believes that a good home is a sustainable home.

As part of its journey to become a net positive business by 2050, Kingfisher recently launched its sustainable growth plan which sets out its sustainability targets for the next seven years. These targets aim to drive lasting change by translating sustainability into a language that connects with customers and the real concerns they have in their homes.
Pro Bono Today: What’s New, What’s Working
We selected 12 companies with reputations for having solid pro bono programs. We interviewed both the company and one of its nonprofit partners. After the interviews, we had to admit that we hadn’t uncovered anything particularly innovative. But we did find a lot to be excited about. The result is the newly published report, “Pro Bono Today: What’s New, What’s Working.”
"My, How Far We've Come"
Each year on June 19, the Taproot Foundation celebrates Matt O'Grady Day, an organization-wide holiday honoring the wedding anniversary of former National Director of Expansion Matt O'Grady. This day also recognizes a major milestone of the civil rights movement - the legalization of gay marriage in California.
Ecocentricity Blog: Go West Young Man
Not hurricanes. Not flooding. Tornadoes are bad news if you run into one, but those fatalities are low too. Lightning strikes don’t hit many people, and blizzards aren’t so bad either. So what else is there?
Shire Commitments to Support Patients as Part of Responsibility Strategy
At Shire, supporting patients is at the heart of being a champion for patients. Beyond discovering and developing medicines, we are committed to dramatically shortening the time to diagnosis for rare diseases, and we aim to support patients along the entire patient journey, from conducting clinical trials to enabling patients to better manage their care through the use of innovative digital technologies, and beyond.
Subscribe to